PT Semen Indonesia (Persero) Tbk
PT Semen Indonesia (Persero) Tbk (PSGTF) Financial Performance & Income Statement Overview
Analyze PT Semen Indonesia (Persero) Tbk (PSGTF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
PT Semen Indonesia (Persero) Tbk (PSGTF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for PT Semen Indonesia (Persero) Tbk PSGTF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7654.75B | $9891.25B | $9883.56B | $8036.26B |
| Cost of Revenue | $6093.39B | $7976.79B | $7724.85B | $6550.23B |
| Gross Profit | $1561.36B | $1914.45B | $2158.71B | $1486.03B |
| Gross Profit Ratio | $0.20 | $0.19 | $0.22 | $0.18 |
| R&D Expenses | $3.41B | $17.50B | $9.80B | $3.02B |
| SG&A Expenses | $560.20B | $436.35B | $737.44B | $578.77B |
| Operating Expenses | $1306.58B | $1603.92B | $2158.71B | $1145.36B |
| Total Costs & Expenses | $7399.97B | $9580.71B | $9249.13B | $7695.59B |
| Interest Income | $39.21B | $98.09B | $19.30B | $65.25B |
| Interest Expense | $218.004B | $260.75B | $276.11B | $326.70B |
| Depreciation & Amortization | $157.52B | $157.43B | $154.61B | $825.31B |
| EBITDA | $467.33B | $595.52B | $788.98B | $1215.15B |
| EBITDA Ratio | $0.06 | $0.06 | $0.08 | $0.15 |
| Operating Income | $254.78B | $310.54B | $634.43B | $340.67B |
| Operating Income Ratio | $0.03 | $0.03 | $0.06 | $0.04 |
| Other Income/Expenses (Net) | -$153.21B | -$124.65B | -$282.67B | -$277.53B |
| Income Before Tax | $101.57B | $185.88B | $351.77B | $63.14B |
| Income Before Tax Ratio | $0.01 | $0.02 | $0.04 | $0.008 |
| Income Tax Expense | $66.14B | $155.66B | $113.81B | $30.48B |
| Net Income | $42.58B | $40.00M | $218.25B | $29.67B |
| Net Income Ratio | $0.006 | $0.00 | $0.02 | $0.004 |
| EPS | $6.00 | $0.006 | $32.33 | $4.39 |
| Diluted EPS | $6.00 | $0.006 | $32.33 | $4.39 |
| Weighted Avg Shares Outstanding | $6.75B | $6.75B | $6.75B | $6.75B |
| Weighted Avg Shares Outstanding (Diluted) | $6.75B | $6.75B | $6.75B | $6.75B |
Over the last four quarters, PT Semen Indonesia (Persero) Tbk's revenue moved from $8036.26B in Q2 2024 to $7654.75B in Q1 2025. Operating income in Q1 2025 was $254.78B, with a strong operating margin of 3%. Despite fluctuations in R&D and SG&A expenses, EBITDA for PT Semen Indonesia (Persero) Tbk remained robust at $467.33B, reflecting operational efficiency. Net income rose to $42.58B, with an EPS of $6.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan